Aduhelm maker Biogen has set up a data network to track how neurological disease medicines perform in the real world after clinical trials. | Aduhelm maker Biogen has set up a data network to track how neurological disease medicines perform in the real world after clinical trials.
Biogen sets up network to leverage real-world data for neurological disease drugs
Posted in biotech/medical